ADXS gave away the rights for nothing upfront except for $10m for the South America deal.
So where is the Biocon trial in India?
GBP and Advaxis plans to execute the multi-center treatment of cervical cancer advanced Phase III clinical trials in 2014. GBP will continue to develop in Asia with Advaxis ADXS-HPV vaccine to treat head and neck cancer, anal cancer."
So where is the GPS trial in Taiwan?
So where is the trial in South America? Oh yeah, Stendhal is suing us for not delivering I think.
Let's face it, DOC's deals weren't simply terrible, they were FRAUDS.
So the question should be where does ADXS still have rights - U.S. and Europe
This is the right question for getting partnership money from Axal Cerv soon. Still nothing from the FDA either on the trial change.
I still hope the trial change was triggered by a partner ready to sign once it's resolved...But then again nothing makes sense out of this company anymore.